Keryx Biopharma (KERX) Misses Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts KERX Hot Sheet
Price: $3.36 --0%
Financial Fact:
Interest and other income, net: 150K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Interest and other income, net: 150K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Keryx Biopharma (NASDAQ: KERX) reported Q4 EPS of ($0.32), $0.07 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $9.5 million versus the consensus estimate of $8.41 million.
For earnings history and earnings-related data on Keryx Biopharma (KERX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Four Tree Island Advisory calls DoubleDown $11.25 offer too low
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
